As GLP-1 drugs for weight loss and diabetes drugs such as Zepbound and Mounjaro generate billions in sales, researchers at Eli Lilly and Co. and other pharma companies are exploring their potential for other purposes.
Dr. Michael Meneghini waited out a two-year noncompete clause after leaving Indiana University Health before opening the $35 million Indiana Orthopedic Institute early this year.
In total, 29 executives—including six CEOs of the Year—will be honored at a 5 p.m. event on Dec. 2 at the Indiana Roof Ballroom. Tickets are still available.
The strategic consulting agreement with the Fort Wayne-based hospital system comes as the Hamilton County-owned Riverview is recovering from consecutive years of operating losses.
Advocates for transgender Hoosiers spoke in opposition to an Indiana Bureau of Motor Vehicles regulation revision to prohibit gender marker changes that have been allowed since 2009.
Kevin Calvert, 57, was charged with 43 counts of Medicaid fraud and an additional count of theft following an investigation by the attorney general’s Medicaid Fraud Control Unit.
The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the presence of the disease’s pathology early on, or indicate further diagnostics are needed.
